We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
GlaxoSmithKline’s (GSK) request that the U.S. Supreme Court review an appeals court ruling allowing Apotex to market a generic version of GSK’s antidepressant Paxi was rejected June 19.